Ramiper

Ramiper

rebamipide

Manufacturer:

Sanbe
Concise Prescribing Info
Contents
Rebamipide
Indications/Uses
Gastric ulcers in combination w/ offensive factor inhibitors (PPIs, anticholinergic, H2 antagonist). Gastritis.
Dosage/Direction for Use
Adult Gastric ulcers 1 tab (100 mg) 3 times daily in combination w/ offensive factor inhibitors to be taken in the morning, evening, & before bedtime. Gastritis 1 tab (100 mg) 3 times daily.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Pregnancy. Interrupt nursing during treatment in nursing woman. Childn. Elderly.
Adverse Reactions
Shock, anaphylactoid reactions; leukopenia & thrombocytopenia; hepatic dysfunction & jaundice. Rash, pruritus, drug-eruption like eczema, other symptoms of hypersensitivity & urticaria; numbness, dizziness, sleepiness; GI effects; increased AST (GOT), ALT (GPT), γ-GTP, & alkaline phosphatase levels; granulocytopenia; menstrual disorders, increased BUN levels, edema & feeling of a foreign body in the pharynx, breast swelling & pain, gynecomastia, induction of lactation, palpitations, fever, facial flushing, numbness of tongue, cough, resp distress & alopecia.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BX14 - rebamipide ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Presentation/Packing
Form
Ramiper FC tab 100 mg
Packing/Price
10 × 10's (Rp425,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in